4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate Summary

Networked: 183 relevant articles (37 outcomes, 49 trials/studies) for this Drug

Key Diseases for which 4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate is Relevant

1. Prostatic Neoplasms (Prostate Cancer) : 26 outcomes 29 studies in 150 results
   
2. Neoplasms (Cancer) : 7 outcomes 14 studies in 29 results
   
3. Neoplasm Metastasis (Metastasis) : 3 outcomes 3 studies in 8 results
   
4. Breast Neoplasms (Breast Cancer) : 1 outcome 4 studies in 8 results
   
5. Disease Progression : 1 outcome 2 studies in 6 results
   

Drugs Related to 4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate

1. docetaxel (Taxotere)
2. abiraterone
3. sipuleucel-T (APC8015)
4. Prednisone (Sone)
5. taxane
6. Mitoxantrone (Novantrone)
7. denosumab
8. Hormones
9. Prednisolone (Predate)
10. capecitabine (Xeloda)

Therapies Related to 4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate

1. Castration
2. Drug Therapy (Chemotherapy)
3. Immunotherapy
4. Heterologous Transplantation (Xenotransplantation)
5. Therapeutics